Palo Alto Investors LP - Mar 24, 2023 Form 4 Insider Report for ALIMERA SCIENCES INC (ALIM)

Role: 10%+ Owner
Signature: /s/ Angela Nguyen-Dinh, Chief Compliance Officer of Palo Alto Investors LP
Stock symbol: ALIM
Transactions as of: Mar 24, 2023
Transactions value $: -$1,252,157
Form type: 4
Date filed: 3/28/2023, 05:13 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALIM	Common Stock	Sale	-$314K	-201K	-100%	$1.56	0	Mar 24, 2023	See note	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALIM	Series A Convertible Preferred Stock	Sale	-$938K	-600K	-100%	$1.56	0	Mar 24, 2023	Common Stock	602K		See note	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Palo Alto Investors LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Palo Alto Investors LP ("PAI") is the investment adviser to private funds, including Palo Alto Healthcare Master Fund, L.P. and Palo Alto Healthcare Master Fund II, L.P. (collectively, the "Funds"). Anthony Joonkyoo Yun, MD and Patrick Lee, MD are the managers and controlling owners of PAI. PAI may be deemed to indirectly beneficially own these securities as the investment adviser to the Funds. Dr. Yun and Dr. Lee may be deemed to indirectly beneficially own them as the control persons of PAI. No single Fund owns more than 10% of the outstanding shares of Common Stock. The reporting person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein.
F2	Each share of Series A Convertible Preferred Stock is convertible into shares of common stock at the rate equal to $40.00 divided by $39.90. The Series A Convertible Preferred Stock does not have an expiration date.

Content

Palo Alto Investors LP ("PAI") is the investment adviser to private funds, including Palo Alto Healthcare Master Fund, L.P. and Palo Alto Healthcare Master Fund II, L.P. (collectively, the "Funds"). Anthony Joonkyoo Yun, MD and Patrick Lee, MD are the managers and controlling owners of PAI. PAI may be deemed to indirectly beneficially own these securities as the investment adviser to the Funds. Dr. Yun and Dr. Lee may be deemed to indirectly beneficially own them as the control persons of PAI. No single Fund owns more than 10% of the outstanding shares of Common Stock. The reporting person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein.

Each share of Series A Convertible Preferred Stock is convertible into shares of common stock at the rate equal to $40.00 divided by $39.90. The Series A Convertible Preferred Stock does not have an expiration date.